Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:770-775

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amann, K.
Right arrow Articles by Ritz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amann, K.
Right arrow Articles by Ritz, E.

(Hypertension. 1997;29:770-775.)
© 1997 American Heart Association, Inc.


Articles

Aortic Changes in Experimental Renal Failure

Hyperplasia or Hypertrophy of Smooth Muscle Cells?

Kerstin Amann; Bettina Wolf; Cornelia Nichols; Johannes Tornig; Ute Schwarz; Martin Zeier; Gerhard Mall; Eberhard Ritz

the Departments of Pathology Heidelberg (K.A., B.W., C.N., J.T., U.S.) and Darmstadt (G.M.), and Department of Internal Medicine (M.Z., E.R.), Ruperto Carola University Heidelberg (Germany).

Correspondence to Dr Kerstin Amann, MD, Department of Pathology, Im Neuenheimer Feld 220, D-69120 Heidelberg, FRG.

Cardiovascular complications are a well-known feature of chronic renal failure. Increased wall thickness of intramyocardial arterioles and elastic (aorta) and peripheral (mesenteric) arteries is seen even after normalization of blood pressure. It is currently unknown whether such increases result from hyperplasia of vascular smooth muscle cells, hypertrophy, or a combination of both or from an increase in aortic extracellular matrix. Using a recently developed unbiased stereological technique (the dissector), we investigated the aortas of subtotally nephrectomized rats and sham-operated controls after perfusion fixation. We determined aortic wall thickness, cross-sectional area of aortic media, total number of vascular smooth muscle cells per unit aortic length (1 mm), mean cell and nuclear volumes, volume density of elastic fibers, extracellular matrix, vascular smooth muscle cells, and total volumes of these structures per unit of aortic length (1 mm). Blood pressure was not significantly increased in subtotally nephrectomized rats. In contrast, wall thickness, cross-sectional media, total number of aortic vascular smooth muscle cells, and volume of extracellular matrix including collagen were significantly increased after subtotal nephrectomy, whereas cellular hypertrophy was only modest and an increase in elastic fibers did not occur. In conclusion, increased aortic wall thickness in experimental renal failure results primarily from an increase in aortic extracellular matrix. In addition, however, proliferation of aortic vascular smooth muscle cells resulting in cell hyperplasia also contributed to aortic wall thickening to a minor degree. It appears that aortic wall thickening is caused by secretory stimulation of the proliferating vascular smooth muscle cells, resulting in increased matrix production. The nature of the underlying stimulus requires further investigation.


Key Words: kidney failure • aorta • hyperplasia • extracellular matrix • muscle, smooth, vascular




This article has been cited by other articles:


Home page
CJASNHome page
J. Nogueira and M. Weir
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Schillaci, M. Pirro, M. R. Mannarino, G. Pucci, G. Savarese, S. S. Franklin, and E. Mannarino
Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension
Hypertension, October 1, 2006; 48(4): 616 - 621.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. E. Safar, G. M London, and G. E. Plante
Arterial Stiffness and Kidney Function
Hypertension, February 1, 2004; 43(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Jolma, P. Koobi, J. Kalliovalkama, H. Saha, M. Fan, J. Jokihaara, E. Moilanen, I. Tikkanen, and I. Porsti
Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2560 - 2569.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Koobi, J. Kalliovalkama, P. Jolma, J. Rysa, H. Ruskoaho, O. Vuolteenaho, M. Kahonen, I. Tikkanen, M. Fan, P. Ylitalo, et al.
AT1 Receptor Blockade Improves Vasorelaxation in Experimental Renal Failure
Hypertension, June 1, 2003; 41(6): 1364 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Amann, C. Ritz, M. Adamczak, and E. Ritz
Why is coronary heart disease of uraemic patients so frequent and so devastating?
Nephrol. Dial. Transplant., April 1, 2003; 18(4): 631 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Buzello, J. Tornig, J. Faulhaber, H. Ehmke, E. Ritz, and K. Amann
The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 311 - 316.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. M. London, S. J. Marchais, A. P. Guerin, F. Metivier, and H. Adda
Arterial structure and function in end-stage renal disease
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1713 - 1724.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. K. GANESH, A. G. STACK, N. W. LEVIN, T. HULBERT-SHEARON, and F. K. PORT
Association of Elevated Serum PO4, Ca PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients
J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2131 - 2138.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Amann and E. Ritz
Microvascular disease--the Cinderella of uraemic heart disease
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1493 - 1503.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
U. Schwarz, M. Buzello, E. Ritz, G. Stein, G. Raabe, G. Wiest, G. Mall, and K. Amann
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
Nephrol. Dial. Transplant., February 1, 2000; 15(2): 218 - 223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Kalliovalkama, P. Jolma, J.-P. Tolvanen, M. Kahonen, N. Hutri-Kahonen, H. Saha, S. Tuorila, E. Moilanen, and I. Porsti
Potassium channel-mediated vasorelaxation is impaired in experimental renal failure
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1622 - H1629.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. TÖRNIG, M.-L. GROSS, A. SIMONAVICIENE, G. MALL, E. RITZ, and K. AMANN
Hypertrophy of Intramyocardial Arteriolar Smooth Muscle Cells in Experimental Renal Failure
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 77 - 83.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Blacher, K. Demuth, A. P. Guerin, M. E. Safar, N. Moatti, and G. M. London
Influence of Biochemical Alterations on Arterial Stiffness in Patients With End-stage Renal Disease
Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-J. Mourad, X. Girerd, P. Boutouyrie, S. Laurent, M. Safar, and G. London
Increased Stiffness of Radial Artery Wall Material in End-Stage Renal Disease
Hypertension, December 1, 1997; 30(6): 1425 - 1430.
[Abstract] [Full Text]